Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada
Clinical trial NCT07718139 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07718139
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-28
- Primary completion
- 2026-09-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.